CD70 binding molecules and methods of use thereof
US-12180292-B2 · Dec 31, 2024 · US
This page is not indexed by search engines while we improve data quality.
Kite Pharma Inc patents in 2024
Kite Pharma Inc was listed as an assignee on 31 patent publications in 2024.
| Metric | Value |
|---|---|
| Company | Kite Pharma Inc |
| Year | 2024 |
| Patents | 31 |
Patents
Representative publications for Kite Pharma Inc in 2024.
Chimeric receptor T cell treatment using characteristics of the tumor microenvironment
US-12156887-B2 · Dec 3, 2024 · US
T cells with improved functionality
US-12152251-B2 · Nov 26, 2024 · US
Allogenic therapeutic cells with reduced risk of immune rejection
US-2024366670-A1 · Nov 7, 2024 · US
Antigen binding molecules and methods of use
US-2024343820-A1 · Oct 17, 2024 · US
Top CPC classifications
Most common classification codes for Kite Pharma Inc in 2024.
| CPC | Patents |
|---|---|
| C07K14/7051 | 22 |
| A61K40/11 | 21 |
| A61K40/31 | 20 |
| A61P35/00 | 18 |
| A61K35/17 | 17 |
Related pages
Navigate to parent entity pages.